# FDA Inspection 1165003 - Kaiser Foundation Hospital Laboratory West Los Angeles - March 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/kaiser-foundation-hospital-laboratory-west-los-angeles/4c05db12-d906-4b11-9fc2-0fc5303a9020
Source feed: FDA_Inspections

> FDA Inspection 1165003 for Kaiser Foundation Hospital Laboratory West Los Angeles on March 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165003
- Company Name: Kaiser Foundation Hospital Laboratory West Los Angeles
- Inspection Date: 2022-03-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1252469 - 2024-10-17](https://www.keypedia.com/records/fda_inspections/kaiser-foundation-hospital-laboratory-west-los-angeles/693c82cd-3b0f-4ba8-aa62-1ddafad7a162)
- [FDA Inspection 1252469 - 2024-10-17](https://www.keypedia.com/records/fda_inspections/kaiser-foundation-hospital-laboratory-west-los-angeles/5e26fc85-71b7-4377-93d7-d42d716055bc)
- [FDA Inspection 1165003 - 2022-03-16](https://www.keypedia.com/records/fda_inspections/kaiser-foundation-hospital-laboratory-west-los-angeles/7e246cb9-7c22-4d7e-a18d-2177709c0aa8)

Company: https://www.keypedia.com/companies/kaiser-foundation-hospital-laboratory-west-los-angeles/2ca1766f-02b3-4a0e-a3ed-7ca32f1750f6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d